» Articles » PMID: 8288752

Mitochondrial Disease and Reduced Sperm Motility

Overview
Journal Hum Reprod
Date 1993 Nov 1
PMID 8288752
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction reduces aerobic energy production and results in symptoms from various tissues, depending on metabolic demands. Mitochondrial adenosine triphosphate (ATP) is essential for sperm motility. Sperm motility was investigated in a patient with a mitochondrial disease caused by reduced activity of the mitochondrial enzyme complexes I and IV, and in two control subjects. Spermatozoa were cultured in media containing various energy substrates. Motility was judged by light microscopy, and ultrastructure by transmission electron microscopy. In the patient with mitochondrial disease, 12% of the spermatozoa were motile in the medium containing only glucose. There was a three-fold increase in motile spermatozoa when pyruvate and succinate were present together with glucose. In contrast, the spermatozoa of both control subjects had best motility in the presence of substrates for complex I, and no further increase was observed when succinate was added. Glucose and pyruvate enter the respiratory chain at complex I, and succinate at complex II. Electron microscopy of spermatozoa from the patient with mitochondrial disease revealed mitochondria with increased matrix, thickening of membranes, parallelization of cristae and lipid inclusions, which are characteristic findings in mitochondrial disorders. Abnormal mitochondria were also found in a spermatid, suggesting that the ultrastructural changes of mitochondria are primary rather than secondary to degeneration of the spermatozoa. The results indicate that mitochondrial dysfunction causes reduced sperm motility in some men.

Citing Articles

The reprotoxic adverse side effects of neurogenic and neuroprotective drugs: current use of human organoid modeling as a potential alternative to preclinical models.

Abady M, Jeong J, Kwon H, Assiri A, Cho J, Saadeldin I Front Pharmacol. 2024; 15:1412188.

PMID: 38948466 PMC: 11211546. DOI: 10.3389/fphar.2024.1412188.


Leukocytospermia and/or Bacteriospermia: Impact on Male Infertility.

Henkel R J Clin Med. 2024; 13(10).

PMID: 38792382 PMC: 11122306. DOI: 10.3390/jcm13102841.


Monitoring of taurine dietary supplementation effect on parameters of Duroc boar ejaculate in summer season.

Pribilova M, Skalickova S, Urbankova L, Baholet D, Nevrkla P, Kopec T PLoS One. 2024; 19(1):e0288317.

PMID: 38271350 PMC: 10810488. DOI: 10.1371/journal.pone.0288317.


Quantitative proteomics of sperm tail in asthenozoospermic patients: exploring the molecular pathways affecting sperm motility.

Mirshahvaladi S, Rezaei Topraggaleh T, Bucak M, Rahimizadeh P, Shahverdi A Cell Tissue Res. 2023; 392(3):793-810.

PMID: 36847810 DOI: 10.1007/s00441-023-03744-y.


Assessment of the Role of Nuclear ENDOG Gene and mtDNA Variations on Paternal Mitochondrial Elimination (PME) in Infertile Men: An Experimental Study.

Eker C, Bilir M, Celik H, Balci B, Gunel T Reprod Sci. 2022; 29(8):2208-2222.

PMID: 35477840 DOI: 10.1007/s43032-022-00953-8.